230 related articles for article (PubMed ID: 6623024)
1. [Pheochromocytoma and sympathetic paragangliomas].
Zollinger R; Hedinger C
Schweiz Med Wochenschr; 1983 Jul; 113(30):1057-65. PubMed ID: 6623024
[TBL] [Abstract][Full Text] [Related]
2. [Pheochromocytoma and sympathetic paraganglioma. 2. Combination with typical associated diseases. Familial occurrence].
Zollinger R; Hedinger C
Schweiz Med Wochenschr; 1983 Aug; 113(31-32):1086-92. PubMed ID: 6137873
[TBL] [Abstract][Full Text] [Related]
3. [Pheochromocytoma--pathohistologic and immunohistochemical aspects].
Tatić S; Havelka M; Paunović I; Bozić V; Diklic A; Brasanac D; Janković R; Jancić-Zguricas M
Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():7-13. PubMed ID: 12584991
[TBL] [Abstract][Full Text] [Related]
4. Nonsporadic cases and unusual morphological features in pheochromocytoma and paraganglioma.
Lamovec J; Frković-Grazio S; Bracko M
Arch Pathol Lab Med; 1998 Jan; 122(1):63-8. PubMed ID: 9448019
[TBL] [Abstract][Full Text] [Related]
5. Clinical and pathological data of 10 malignant pheochromocytomas: long-term follow up in a single institute.
Huang KH; Chung SD; Chen SC; Chueh SC; Pu YS; Lai MK; Lin WC
Int J Urol; 2007 Mar; 14(3):181-5. PubMed ID: 17430251
[TBL] [Abstract][Full Text] [Related]
6. [Incidence of medullary thyroid gland carcinoma in unilateral and bilateral pheochromocytoma].
Pusterla E; Hedinger C
Schweiz Med Wochenschr; 1975 Jan; 105(3):83-7. PubMed ID: 1121658
[TBL] [Abstract][Full Text] [Related]
7. [Can pheochromocytoma be considered a benign unilateral intra-adrenal sporadic hypertensive tumor ? Reflections on a series of 105 surgically treated subdiaphragmatic chromaffin tumors].
Proye C; Vix M; Goropoulos A; Carnaille B; Vermesse B; Kerlo P; Lecomte-Houcke M
Chirurgie; 1992; 118(8):433-8. PubMed ID: 1343986
[TBL] [Abstract][Full Text] [Related]
8. Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators.
Ayala-Ramirez M; Feng L; Johnson MM; Ejaz S; Habra MA; Rich T; Busaidy N; Cote GJ; Perrier N; Phan A; Patel S; Waguespack S; Jimenez C
J Clin Endocrinol Metab; 2011 Mar; 96(3):717-25. PubMed ID: 21190975
[TBL] [Abstract][Full Text] [Related]
9. Pathology of pheochromocytoma and extra-adrenal paraganglioma.
Tischler AS; Kimura N; Mcnicol AM
Ann N Y Acad Sci; 2006 Aug; 1073():557-70. PubMed ID: 17102124
[TBL] [Abstract][Full Text] [Related]
10. KI-67 AND hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma.
Elder EE; Xu D; Höög A; Enberg U; Hou M; Pisa P; Gruber A; Larsson C; Bäckdahl M
Mod Pathol; 2003 Mar; 16(3):246-55. PubMed ID: 12640105
[TBL] [Abstract][Full Text] [Related]
11. Intra-tumoral molecular heterogeneity in benign and malignant pheochromocytomas and extra-adrenal sympathetic paragangliomas.
Korpershoek E; Stobbe CK; van Nederveen FH; de Krijger RR; Dinjens WN
Endocr Relat Cancer; 2010 Sep; 17(3):653-62. PubMed ID: 20488782
[TBL] [Abstract][Full Text] [Related]
12. [Malignant pheochromocytoma. A case report and comments on a rare pathology].
Boneschi M; Erba M; Rinaldi P; Cusmai F; Miani S
Minerva Chir; 1999; 54(1-2):73-8. PubMed ID: 10230231
[TBL] [Abstract][Full Text] [Related]
13. Changes in urinary total metanephrine excretion in recurrent and malignant pheochromocytomas and secreting paragangliomas.
Amar L; Peyrard S; Rossignol P; Zinzindohoue F; Gimenez-Roqueplo AP; Plouin PF
Ann N Y Acad Sci; 2006 Aug; 1073():383-91. PubMed ID: 17102107
[TBL] [Abstract][Full Text] [Related]
14. [Biological study the paragangliomas in a case of Sipple's syndrome].
Masse-Labadie G; Duc M
C R Seances Soc Biol Fil; 1967; 161(6):1407-11. PubMed ID: 4232823
[No Abstract] [Full Text] [Related]
15. Paragangliomas: etiology, presentation, and management.
Joynt KE; Moslehi JJ; Baughman KL
Cardiol Rev; 2009; 17(4):159-64. PubMed ID: 19525677
[TBL] [Abstract][Full Text] [Related]
16. [Personal experience in diagnosis and localization of pheochromocytoma].
Andjelković Z; Tavcar I
Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():14-9. PubMed ID: 12584992
[TBL] [Abstract][Full Text] [Related]
17. Malignant pheochromocytomas and paragangliomas: molecular signaling pathways and emerging therapies.
Santarpia L; Habra MA; Jiménez C
Horm Metab Res; 2009 Sep; 41(9):680-6. PubMed ID: 19343618
[TBL] [Abstract][Full Text] [Related]
18. Endoscopic treatment of solitary, bilateral, multiple, and recurrent pheochromocytomas and paragangliomas.
Walz MK; Peitgen K; Neumann HP; Janssen OE; Philipp T; Mann K
World J Surg; 2002 Aug; 26(8):1005-12. PubMed ID: 12045858
[TBL] [Abstract][Full Text] [Related]
19. Pheochromocytomas and extra-adrenal paragangliomas detected by screening in patients with SDHD-associated head-and-neck paragangliomas.
Havekes B; van der Klaauw AA; Weiss MM; Jansen JC; van der Mey AG; Vriends AH; Bonsing BA; Romijn JA; Corssmit EP
Endocr Relat Cancer; 2009 Jun; 16(2):527-36. PubMed ID: 19289533
[TBL] [Abstract][Full Text] [Related]
20. Fine needle aspiration cytology of paraganglionic tumors.
González-Cámpora R; Otal-Salaverri C; Panea-Flores P; Lerma-Puertas E; Galera-Davidson H
Acta Cytol; 1988; 32(3):386-90. PubMed ID: 3376706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
